These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29487401)
1. Are immunotherapies for Huntington's disease a realistic option? Denis HL; Lauruol F; Cicchetti F Mol Psychiatry; 2019 Mar; 24(3):364-377. PubMed ID: 29487401 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapies in Huntington's disease and α-Synucleinopathies. Fatoba O; Ohtake Y; Itokazu T; Yamashita T Front Immunol; 2020; 11():337. PubMed ID: 32161599 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Strategies for Huntington's Disease Treatment. Colpo GD; Rocha NP; Stimming EF; Teixeira AL CNS Neurol Disord Drug Targets; 2017; 16(8):936-944. PubMed ID: 28606048 [TBL] [Abstract][Full Text] [Related]
4. Treating the whole body in Huntington's disease. Carroll JB; Bates GP; Steffan J; Saft C; Tabrizi SJ Lancet Neurol; 2015 Nov; 14(11):1135-42. PubMed ID: 26466780 [TBL] [Abstract][Full Text] [Related]
5. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies. Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802 [TBL] [Abstract][Full Text] [Related]
6. Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. Wolfgang WJ; Miller TW; Webster JM; Huston JS; Thompson LM; Marsh JL; Messer A Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11563-8. PubMed ID: 16061794 [TBL] [Abstract][Full Text] [Related]
20. Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes. Miller JR; Träger U; Andre R; Tabrizi SJ PLoS One; 2015; 10(11):e0141793. PubMed ID: 26529236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]